• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clin Chim Acta . A Nomogram to Early Predict Isolation Length for Non-severe COVID-19 Patients Based on Laboratory Investigation: A Multicenter Ret

tetano

Editor, Senior Moderator
Clin Chim Acta


. 2020 Dec 3;S0009-8981(20)30552-0.
doi: 10.1016/j.cca.2020.11.019. Online ahead of print.
A Nomogram to Early Predict Isolation Length for Non-severe COVID-19 Patients Based on Laboratory Investigation: A Multicenter Retrospective Study in Zhejiang Province, China


Yan Xia[SUP] 1 [/SUP], Yan Zhang[SUP] 2 [/SUP], Shijin Yuan[SUP] 1 [/SUP], Jiangnan Chen[SUP] 3 [/SUP], Wei Zheng[SUP] 4 [/SUP], Xiaoping Xu[SUP] 5 [/SUP], Xinyou Xie[SUP] 6 [/SUP], Jun Zhang[SUP] 7 [/SUP]



Affiliations

Abstract

Background: Majority coronavirus disease 2019 (COVID-19) patients are classified as mild and moderate (non-severe) diseases. We aim to develop a model to predict isolation length for non-severe patients.
Methods: Among 188 non-severe patients, 96 patients were enrolled as training cohort to identify factors associated with isolation length via Cox regression model and develop a nomogram. Other 92 patients formed as validation cohort to validate nomogram. Concordance index (C-index), area under the curve (AUC) and calibration curves were used to evaluated nomogram.
Results: Increasing absolute eosinophil count (AEC) after admission was correlated with shorter isolation length (P=0.02). Baseline activated partial thromboplastin time (APTT) > 30s was correlated with longer isolation length (P=0.03). A nomogram to predict isolation probability at 11-, 16- and 21-day was developed and validated. The C-indices of training and validation cohort were 0.604 and 0.682 respectively. Both cohorts showed a good discriminative ability (AUC, 11-day: 0.646 vs 0.730; 16-day: 0.663 vs 0.750; 21-day: 0.711 vs 0.783; respectively) and calibration power.
Conclusions: Baseline APTT and dynamic change of AEC were two significant factors associated with isolation length of non-severe patients. Nomogram could predict isolation probability for each patient to estimate appropriate quarantine length.

Keywords: Absolute eosinophil count; Activated partial thromboplastin time; COVID-19; Isolation length; Nomogram.
 
Back
Top Bottom